Literature DB >> 13489643

Therapeutic trial of iproniazid (marsilid) in depressed and apathetic patients.

R L DEVERTEUIL, H E LEHMANN.   

Abstract

Entities:  

Keywords:  DEPRESSION/therapy; NICOTINIC ACID ISOMERS/therapeutic use; PSYCHOSES/therapy

Mesh：

Substances：

Year:  1958        PMID： 13489643      PMCID： PMC1829550     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN： 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  6 in total

1.  Clinical observations with frenquel in chronic schizophrenia.

Authors:  O LINDAN; C H CAHN; H E LEHMANN
Journal:  Can Psychiatr Assoc J       Date:  1956-04

2.  Biochemical findings relating to the action of serotonin.

Authors:  S UDENFRIEND; H WEISSBACH; D F BOGDANSKI
Journal:  Ann N Y Acad Sci       Date:  1957-03-14       Impact factor: 5.691

3.  Intravenous administration of nitrogen mustard alone and with corticotropin for rheumatoid arthritis.

Authors:  A L SCHERBEL
Journal:  Cleve Clin Q       Date:  1957-04

4.  The nature of drugs with mental actions and their relation to cerebral function.

Authors:  H H PENNES
Journal:  Bull N Y Acad Med       Date:  1957-02

5.  Anxiety and depressive states treated with isonicotinyl hydrazide (isoniazid).

Authors:  H M SALZER; M L LURIE
Journal:  AMA Arch Neurol Psychiatry       Date:  1953-09

6.  The effect of 1-isonicotynl 2-isopropyl hydrazide (IIH) on the behavior of long-term mental patients.

Authors:  G R KAMMAN; J G FREEMAN; R J LUCERO
Journal:  J Nerv Ment Dis       Date:  1953-11       Impact factor: 2.254
  6 in total
  15 in total

1.  Liver-function tests in patients receiving iproniazid.

Authors:  L ZETZEL; H KAPLAN; K T DUSSIK
Journal:  Am J Dig Dis       Date:  1959-12

2.  Jaundice following iproniazid administration with recovery; serial biochemical and histological observations of two patients.

Authors:  S P BRALOW; H SHAY
Journal:  Am J Dig Dis       Date:  1959-12

3.  Jaundice associated with administration of iproniazid; report of two cases.

Authors:  S BENAIM; M F DIXON
Journal:  Br Med J       Date:  1958-11-01

4.  Hepatitis associated with iproniazid (marsilid); report of 3 cases.

Authors:  H G LEVIN; J E BERK; L J PAUL; C BERMAN
Journal:  Am J Dig Dis       Date:  1959-04

5.  Dangerous potentiation of pethidine by iproniazid, and its treatment.

Authors:  J C SHEE
Journal:  Br Med J       Date:  1960-08-13

6.  A clinical and biochemical study of a trial of iproniazid in the treatment of depression.

Authors:  C M PARE; M SANDLER
Journal:  J Neurol Neurosurg Psychiatry       Date:  1959-08       Impact factor: 10.154

Review 7.  Sigma receptors: potential targets for a new class of antidepressant drug.

Authors:  James A Fishback; Matthew J Robson; Yan-Tong Xu; Rae R Matsumoto
Journal:  Pharmacol Ther       Date:  2010-05-11       Impact factor: 12.310

Review 8.  Type A monoamine oxidase and serotonin are coordinately involved in depressive disorders: from neurotransmitter imbalance to impaired neurogenesis.

Authors:  Makoto Naoi; Wakako Maruyama; Masayo Shamoto-Nagai
Journal:  J Neural Transm (Vienna)       Date:  2017-03-14       Impact factor: 3.575

9.  Revitalizing psychiatric therapeutics.

Authors:  Steven E Hyman
Journal:  Neuropsychopharmacology       Date:  2014-01       Impact factor: 7.853

10.  Clinical trial with desmethylimipramine (G-35020), a new antidepressive compound.

Authors:  T A BAN; H E LEHMANN
Journal:  Can Med Assoc J       Date:  1962-06-02       Impact factor: 8.262
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.